FDA sets Dec. PDUFA date for Urovant rival to Astellas drug

FDA sets Dec. PDUFA date for Urovant rival to Astellas drug

Submitted by admin on March 6, 2020 - 10:42am
Source: 
Fierce Biotech
News Tags: 
Urovant Sciences
overactive bladder
vibegron
FDA
Headline: 
FDA sets Dec. PDUFA date for Urovant rival to Astellas drug
snippet: 

The FDA has accepted Urovant Sciences’ filing for approval of overactive bladder prospect vibegron, teeing the biotech up to find out whether it has won approval in the final few days of 2020.

Do Not Allow Advertisers to Use My Personal information